The risk of secondary malignancies over 30 years after the treatment of non-hodgkin lymphoma [1]

Cancer

Volumn 107, Issue 11, 2006, Pages 2741-2742

  Brown, Linda Morris ^a   Howard, Regan A ^a   Travis, Lois B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; FEMALE; FOLLOW UP; GERM CELL TUMOR; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; SECOND CANCER; TESTIS CANCER;

BREAST NEOPLASMS; FINLAND; HUMANS; MESOTHELIOMA; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SCANDINAVIA;

EID: 33751581910     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22309     Document Type: Letter

References (2)

1. Tward JD, Wendland MMM, Shrieve DC, Szabo A, Gaffney DK. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer. 2006;107:108-115.
2. Travis LB, Fossa SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005;97:1354-1365.